SEASTAR MEDICAL HOLDING CORP (ICU) Stock Earnings & Estimates
USA - NASDAQ:ICU - US81256L2034 - Common Stock
0.3118 USD
-0.02 (-6.95%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 135K | 1.242M 820.00% | 2.029M 63.37% | |||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.61M -160.90% | -14.21M -22.39% | -17.842M -25.56% | -15.053M 15.63% | -19.602M -30.22% | |
| Operating Margin | N/A | N/A | -13,216.30% | -1,212.00% | -966.10% | |
| EPS YoY % growth | N/A | N/A | -7.78 73.21% | -0.73 90.65% | -0.45 37.50% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 85.41% | -0.11 74.75% | -0.11 38.28% | -0.11 14.54% | -0.11 15.38% |
| Revenue Q2Q % growth | 247.45K 269.33% | 378.75K 29.27% | 477.73K 41.34% | 354.51K 93.72% | 653.47K 164.08% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.962M 16.88% | -4.159M -8.82% | -4.42M -151.69% | -4.997M -13.41% | -5.213M -31.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.13 88.18% | -0.15 | 0.02 | 14.19% |
| Q2 2025 Q2Q % growth | -0.18 82.52% | -0.43 | 0.25 | 58.55% |
| Q1 2025 Q2Q % growth | -0.44 90.74% | -0.53 | 0.09 | 16.22% |
| Q4 2024 Q2Q % growth | -0.90 83.64% | -0.90 | 0.00 | -0.12% |
| Q3 2024 Q2Q % growth | -1.10 87.78% | -1.14 | 0.04 | 3.62% |
| Q2 2024 Q2Q % growth | -1.03 85.29% | -1.42 | 0.39 | 27.67% |
| Q1 2024 Q2Q % growth | -4.75 | -3.79 | -0.96 | -25.41% |
| Q4 2023 Q2Q % growth | -5.50 | -3.28 | -2.22 | -67.56% |
| Q3 2023 Q2Q % growth | -9.00 | -6.31 | -2.69 | -42.57% |
| Q2 2023 Q2Q % growth | -7.00 | -6.31 | -0.69 | -10.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 183K 169.12% | 252.5K | -69.5K | -27.52% |
| Q2 2025 Q2Q % growth | 338K | 202K | 136K | 67.33% |
| Q1 2025 Q2Q % growth | 293K | 151.5K | 141.5K | 93.40% |
| Q4 2024 Q2Q % growth | 67K | 151.5K | -84.5K | -55.78% |
| Q3 2024 Q2Q % growth | 68K | 75.75K | -7.75K | -10.23% |
| Q2 2024 Q2Q % growth | 10.1K | -10.1K | -100.00% | |
| Q1 2024 Q2Q % growth | 151.5K | -151.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 59.46% | 6.49% | 53.55% |
| Revenue | 0% | 0% | 0% | 7.72% |